Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$9.71 - $15.86 $1.03 Million - $1.69 Million
-106,415 Reduced 20.19%
420,749 $4.3 Million
Q3 2022

Nov 14, 2022

BUY
$10.96 - $15.45 $548,000 - $772,500
50,000 Added 10.48%
527,164 $7.76 Million
Q2 2022

Aug 15, 2022

BUY
$7.41 - $11.56 $389,669 - $607,905
52,587 Added 12.39%
477,164 $5.12 Million
Q1 2022

May 16, 2022

BUY
$9.89 - $17.25 $27,692 - $48,300
2,800 Added 0.66%
424,577 $4.58 Million
Q4 2021

Feb 14, 2022

SELL
$16.14 - $25.04 $364,618 - $565,678
-22,591 Reduced 5.08%
421,777 $6.88 Million
Q3 2021

Nov 15, 2021

BUY
$17.52 - $27.93 $7.79 Million - $12.4 Million
444,368 New
444,368 $9.51 Million

Others Institutions Holding CTKB

About Cytek Biosciences, Inc.


  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $920M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.